Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS‐induced acute lung injury

Acute inflammatory diseases are the leading causes of mortality in intensive care units. Myeloid differentiation 2 (MD‐2) is required for recognizing lipopolysaccharide (LPS) by toll‐like receptor 4 (TLR4), and represents an attractive therapeutic target for LPS‐induced inflammatory diseases. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yali, Xu, Tingting, Wu, Beibei, Chen, Hongjin, Pan, Zheer, Huang, Yi, Mei, Liqin, Dai, Yuanrong, Liu, Xing, Shan, Xiaoou, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345657/
https://www.ncbi.nlm.nih.gov/pubmed/27860279
http://dx.doi.org/10.1111/jcmm.13017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345657/
https://www.ncbi.nlm.nih.gov/pubmed/27860279
http://dx.doi.org/10.1111/jcmm.13017

Ejemplares similares